Piper Sandler reaffirmed their neutral rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report published on Tuesday morning, Benzinga reports. The brokerage currently has a $4.00 target price on the stock. HUMA has been the topic of several other reports. HC Wainwright assumed coverage on shares of Humacyte in a research report […]
Benchmark reiterated their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report published on Monday, Benzinga reports. They currently have a $15.00 price target on the stock. Separately, HC Wainwright assumed coverage on Humacyte in a report on Monday, December 11th. They issued a buy rating and a $6.00 target price […]
Humacyte to Host Virtual KOL Event "Hemodialysis Access: A Crossroads of Care," on March 28, 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Humacyte (NASDAQ:HUMA – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Benchmark in a research note issued to investors on Monday, Benzinga reports. They currently have a $15.00 price target on the stock. Benchmark’s target price indicates a potential upside of 365.84% from the stock’s current price. Separately, HC Wainwright […]
Humacyte (NASDAQ:HUMA – Get Free Report) announced its earnings results on Friday. The company reported ($0.24) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.01, Yahoo Finance reports. During the same quarter last year, the firm posted ($0.21) EPS. Humacyte Stock Performance Shares of NASDAQ:HUMA opened at $3.31 on […]